Achmea Investment Management B.V. Acquires 103,857 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Achmea Investment Management B.V. boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 42.5% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 348,130 shares of the pharmacy operator's stock after buying an additional 103,857 shares during the period. Achmea Investment Management B.V.'s holdings in Walgreens Boots Alliance were worth $3,889,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Riverview Trust Co increased its holdings in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,590 shares during the period. Colonial Trust Co SC grew its position in Walgreens Boots Alliance by 79.5% during the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,297 shares in the last quarter. Sentry Investment Management LLC bought a new position in Walgreens Boots Alliance during the 1st quarter worth $27,000. Curat Global LLC acquired a new position in Walgreens Boots Alliance in the 1st quarter valued at $27,000. Finally, Private Trust Co. NA raised its holdings in Walgreens Boots Alliance by 35.5% in the 4th quarter. Private Trust Co. NA now owns 4,585 shares of the pharmacy operator's stock valued at $43,000 after acquiring an additional 1,200 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Insider Activity at Walgreens Boots Alliance

In other news, Chairman Stefano Pessina acquired 832,258 shares of the business's stock in a transaction that occurred on Sunday, April 27th. The shares were bought at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the acquisition, the chairman directly owned 145,621,079 shares in the company, valued at $1,603,288,079.79. The trade was a 0.57% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 17.50% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently commented on WBA shares. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a "hold" rating on the stock. UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Finally, Morgan Stanley restated an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Price Performance

Shares of WBA stock traded down $0.03 on Wednesday, reaching $11.47. The company had a trading volume of 3,092,308 shares, compared to its average volume of 17,871,367. The business's 50-day moving average is $11.23 and its 200 day moving average is $10.85. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $13.25. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $9.92 billion, a PE ratio of -1.57, a price-to-earnings-growth ratio of 1.36 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, beating the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The business had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. During the same quarter in the prior year, the firm earned $0.63 EPS. The firm's revenue was up 7.2% compared to the same quarter last year. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.